MEK inhibitor-based combination therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEK inhibitor-based combination therapy, covering 2025-04-24 to 2025-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy